Apollomics, Inc.
NASDAQ: APLMW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Guo-Liang Yu
- Employees
- 13
- Headquarters
- Foster City, United States
- IPO year
- 2023
- Market cap
- $249.8M
- Website
- http://www.apollomicsinc.com
Loading APLMW…
Loading profile data…Frequently asked questions about APLMW
What does Apollomics, Inc. (APLMW) do?
Apollomics, Inc. functions as a clinical-phase biotechnology enterprise, concentrating its efforts on discovering and advancing novel cancer treatments to meet crucial, underserved patient requirements. The company was co-founded by Liang Yu Guo and Sanjeev Redkar in 2015, with its main operations based in Foster City, California.
Where does APLMW trade?
Apollomics, Inc. (APLMW) trades on the NASDAQ Capital Market.
What sector is APLMW in?
Apollomics, Inc. (APLMW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Apollomics, Inc.?
Guo-Liang Yu is the chief executive officer of Apollomics, Inc. (APLMW).
Where is Apollomics, Inc. headquartered?
Apollomics, Inc. is headquartered in United States.
Does APLMW pay a dividend?
Apollomics, Inc. (APLMW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did APLMW go public?
Apollomics, Inc. (APLMW) completed its initial public offering in 2023.